Emcure Pharmaceuticals Limited – FDA 483, Feb 25, 2025
Emcure Pharmaceuticals Limited, an API manufacturer in Pune, Maharashtra, India, was issued a Form 483 following an inspection from February 19-25, 2025. The inspection revealed significant deficiencies in equipment cleaning, cleaning validation, and maintenance procedures, including visible residues and improper use of materials. Additionally, the firm failed to adequately document and verify training records for personnel involved in manufacturing and cGMP.
ID · 71d48499-1520-40b7-ba9f-0ff48488110e
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.